UK's University of Strathclyde has acquired a powerful laser with multiple scientific applications such as medical imaging and cancer treatment.

Designed and built by technology firm Thales, the laser is reported to recreate the stars' physical conditions such as pressures and temperatures. It also has a high repetition rate for peak powers and the capacity to emit the bursts of light that are equivalent to 20-times the power consumed on Earth in a fraction of a second.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Currently available at the Strathclyde-based Scottish Centre for the Application of Plasma-based Accelerators (SCAPA), the laser has applications in radiotherapy and generating radioisotopes for imaging and cancer therapy.

Strathclyde Physics Department research fellow and SCAPA laser manager Dr Gregor Welsh said: “This is a world-leading laser for any university. Indeed, we believe it is the highest average powered lab-based laser of its type anywhere in the world.

“It acts as a light source which drives the applications and produces X-ray pulses that are short enough to take snapshots of molecular or solid-state processes.”

"Our acquisition of this type of laser reflects Strathclyde’s status as a world-class centre of physics."

The laser is capable of producing beams with peak power of 350TW for 25 femtoseconds. It can produce approximately 14J of energy per pulse at five pulses per second (5Hz).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

SCAPA director professor Dino Jaroszynski said: “Our acquisition of this type of laser reflects Strathclyde’s status as a world-class centre of physics.

“Its important applications underline Strathclyde’s international reputation for research with impact. It also forms part of a valuable training facility for PhD students.”    

Worth £3.5m, the device has been funded by Strathclyde and the Scottish Universities Physics Alliance (SUPA).

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact